We observed that patient tumor lysatesexpressed higher levels of active Cat L as compared to normal matched patienttissue (Fig 1A and 1B).Unfortunately, receptor status on these patient samples was not available fromthe pathology case reports to correlate to Cat L activity. The gene discussed is CTSL; the disease is neoplasm.